Abstract
The original structure of a high-throughput screening hit obtained from an external vendor was revised based on multiple NMR studies. The active compound was re-synthesized via a novel route and its structure and biological activity as a BRS-3 agonist were unambiguously confirmed. Multi-gram quantities of the hit were prepared for pharmacokinetic and efficacy studies. The synthetic strategy allowed for the preparation of multiple analogs for SAR exploration.
2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Anti-Obesity Agents / chemical synthesis*
-
Anti-Obesity Agents / chemistry
-
Anti-Obesity Agents / pharmacokinetics
-
High-Throughput Screening Assays
-
Humans
-
Naphthyridines / chemical synthesis*
-
Naphthyridines / chemistry
-
Naphthyridines / pharmacokinetics
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacokinetics
-
Rats
-
Receptors, Bombesin / agonists*
-
Receptors, Bombesin / metabolism
-
Structure-Activity Relationship
Substances
-
7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo(3,4-c)(2,7)-naphthyridin-1-ylamine
-
Anti-Obesity Agents
-
Naphthyridines
-
Pyrazoles
-
Receptors, Bombesin
-
bombesin receptor subtype 3